8-K: PetMed Express Receives Nasdaq Delisting Notice for Delayed 10-K Filing

PetMed Express, Inc. received an expected notice from Nasdaq regarding non-compliance due to the delayed filing of its Annual Report on Form 10-K for the fiscal year ended March 31, 2025.

Summary

• PetMed Express, Inc. (PetMeds) received a notice from The Nasdaq Stock Market LLC on July 2, 2025, indicating non-compliance with Nasdaq Listing Rule 5250(c)(1).
• The non-compliance stems from the company's failure to timely file its Annual Report on Form 10-K for the fiscal year ended March 31, 2025, with the SEC.
• The company previously disclosed its inability to file the Form 10-K by the due date due to ongoing efforts to compile, review, and analyze necessary information for its financial statements and disclosures.
• The notice has no immediate effect on the listing or trading of PetMeds' common stock on Nasdaq.
• PetMeds must submit a plan to regain compliance within 60 calendar days, by September 1, 2025.
• Nasdaq may grant an exception of up to 180 calendar days from the Form 10-K due date, or until December 29, 2025, for the company to regain compliance.
• PetMeds is working diligently to complete its financial statements and the Form 10-K, planning to file it as soon as practicable to regain compliance.

Sentiment

Score: 4

Explanation: The document reports a regulatory non-compliance issue (delayed 10-K filing) which is negative, but it was an 'expected' notice with 'no immediate effect' on listing, and the company has a clear path to compliance. This mitigates the immediate negative impact, placing it slightly below neutral.

Positives

• The notice from Nasdaq was expected, indicating the company was aware of the potential non-compliance.
• The notice has no immediate effect on the listing or trading of the company's common stock on Nasdaq.
• Nasdaq provides a clear pathway for compliance, allowing up to 180 calendar days from the Form 10-K due date (until December 29, 2025) to regain compliance, provided a plan is submitted.

Negatives

• PetMed Express, Inc. is not in compliance with Nasdaq Listing Rule 5250(c)(1) due to the delayed filing of its Annual Report on Form 10-K for the fiscal year ended March 31, 2025.
• The company was unable to file its Form 10-K by the prescribed due date without unreasonable effort or expense, indicating internal challenges in financial reporting.
• The delay requires the company to submit a plan to regain compliance within 60 days, adding administrative burden and scrutiny.

Risks

• Inability to complete the filing of the Form 10-K within the anticipated time period.
• Failure to regain compliance with Nasdaq listing standards, which could lead to delisting.
• The time and effort required to complete the company's financial statements for its fiscal year ending March 31, 2025, may be more extensive than currently anticipated.
• Future results may be impacted by other risk factors listed in previous SEC filings, including the Annual Report on Form 10-K for the year ended March 31, 2024, and subsequent filings.

Future Outlook

The company is working diligently to complete its financial statements for the fiscal year ending March 31, 2025, and the Form 10-K, with plans to file it as soon as practicable to regain compliance with Nasdaq listing rules.

Management Comments

• "While the Company can provide no assurances as to timing, the Company is working diligently to complete its financial statements for its fiscal year ending March 31, 2025, and the Form 10-K and plans to file the Form 10-K as soon as practicable to regain compliance with the Listing Rule."

Industry Context

PetMed Express, Inc. operates in the direct-to-consumer pet healthcare sector, functioning as a national online pharmacy licensed across all 50 states, offering pharmaceuticals, compounded medications, and OTC supplements for pets. This announcement is specific to the company's regulatory compliance and does not provide broader industry trends or competitive analysis.

Stakeholder Impact

• Shareholders: Face uncertainty regarding the company's financial health due to the delayed 10-K and potential risk of delisting if compliance is not regained, though there is no immediate effect on trading.
• Regulatory Authorities: The SEC and Nasdaq are actively monitoring the company's compliance with filing requirements.

Next Steps

• Submit a plan to Nasdaq to regain compliance with Listing Rule 5250(c)(1) by September 1, 2025.
• Complete and file the Annual Report on Form 10-K for the fiscal year ended March 31, 2025, as soon as practicable.
• Regain compliance with Nasdaq listing standards, potentially by December 29, 2025, if an exception is granted.

Key Dates

Keywords

PetMed Express, PetMeds, PETS, Nasdaq, 10-K, SEC filing, non-compliance, delisting notice, financial reporting, delayed filing, corporate governance, pet healthcare